8V29 | pdb_00008v29

Cryo-EM structure of human type I OSM receptor complex: model for full extracellular assembly


Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

ChainsTypeFamily Name Domain Identifier Family IdentifierProvenance Source (Version)
BSCOP2B SuperfamilyFibronectin type III 8055533 3002063 SCOP2B (2022-06-29)
BSCOP2B SuperfamilyFibronectin type III 8055145 3002063 SCOP2B (2022-06-29)
ASCOP2B Superfamily4-helical cytokines 8037083 3001717 SCOP2B (2022-06-29)

Protein Family Annotation Pfam Database Homepage

ChainsAccessionNameDescriptionCommentsSource
PF21177Leukemia inhibitory factor receptor, Ig-like domain (LIF-R_Ig-like)Leukemia inhibitory factor receptor, Ig-like domainThis domain is found in Leukemia inhibitory factor receptor from mouse (LIF-R) and similar proteins from animals. LIF-R binds a cytokine that acts on many cell types including embryonic stem cells, megakaryocytes, osteoblasts, and neuronal cells. The ...This domain is found in Leukemia inhibitory factor receptor from mouse (LIF-R) and similar proteins from animals. LIF-R binds a cytokine that acts on many cell types including embryonic stem cells, megakaryocytes, osteoblasts, and neuronal cells. The extracellular region of this protein shows a modular structure with two cytokine-binding modules (CBM, with Pfam:PF17971 representing the second subdomain of CBM1, D2) separated by an Ig-like domain (this entry) and followed by three membrane- proximal fibronectin type-III (FNIII) domains (Pfam:PF00041) This domain interacts directly with site 3 of Cilliary Neutrophic Factor (CNTF) [1,2].
Domain
PF17971Leukemia inhibitory factor receptor D2 domain (LIFR_D2)Leukemia inhibitory factor receptor D2 domainThis is the D2 domain in cytokine-binding module 1 (CBM1) found in Leukemia inhibitory factor receptor (LIFR) and OSM receptors (OSMR). LIFR has an extracellular region with a modular structure containing two cytokine-binding modules (CBM) separated ...This is the D2 domain in cytokine-binding module 1 (CBM1) found in Leukemia inhibitory factor receptor (LIFR) and OSM receptors (OSMR). LIFR has an extracellular region with a modular structure containing two cytokine-binding modules (CBM) separated by an Ig-like domain and followed by three membrane-proximal fibronectin type-III (FNIII) domains. The D2 domain in CBM1 shows structural similarity to the corresponding CBM domains of both gp130 and IL-6Ralpha because it contains conserved structural features like the WSXWS motif [1] [2]. The WSXWS motif in cytokine receptors is a molecular switch involved in receptor activation [3].
Domain
PF25552Leukemia inhibitory factor receptor D4 domain (LIFR_D4)Leukemia inhibitory factor receptor D4 domainThis entry describes the domain 4 in Leukemia inhibitory factor regulator (LIFR) and other type I cytokine receptors found in mammals. They are involved in signal transduction for various cytokines, playing crucial roles in immune response, hematopoi ...This entry describes the domain 4 in Leukemia inhibitory factor regulator (LIFR) and other type I cytokine receptors found in mammals. They are involved in signal transduction for various cytokines, playing crucial roles in immune response, hematopoiesis, and development. LIFR extracellular region is composed of D1-D2 (Pfam:PF17971) which is a cytokine binding homology region (CHR) followed by an Ig-like domain D3 (Pfam:PF21177), another CHR region composed of D4 and D5 [1-2] and three membrane-proximal fibronectin type-III (FNIII) domains (Pfam:PF00041).
Domain
PF00041Fibronectin type III domain (fn3)Fibronectin type III domainDomain
PF18207Leukemia inhibitory factor receptor N-terminal domain (LIFR_N)Leukemia inhibitory factor receptor N-terminal domainThis domain can be found in leukemia inhibitory factor receptor (LIFR). LIFR is a cell surface receptor that mediates the actions of LIF and other interleukin-6 type cytokines through the formation of signalling complexes with gp130. This is the N-te ...This domain can be found in leukemia inhibitory factor receptor (LIFR). LIFR is a cell surface receptor that mediates the actions of LIF and other interleukin-6 type cytokines through the formation of signalling complexes with gp130. This is the N-terminal domain, referred to as domain 1, which contains conserved disulfide bonds between Cys-10 to Cys-20 and Cys-37 to Cys-45 [1].
Domain
PF25552Leukemia inhibitory factor receptor D4 domain (LIFR_D4)Leukemia inhibitory factor receptor D4 domainThis entry describes the domain 4 in Leukemia inhibitory factor regulator (LIFR) and other type I cytokine receptors found in mammals. They are involved in signal transduction for various cytokines, playing crucial roles in immune response, hematopoi ...This entry describes the domain 4 in Leukemia inhibitory factor regulator (LIFR) and other type I cytokine receptors found in mammals. They are involved in signal transduction for various cytokines, playing crucial roles in immune response, hematopoiesis, and development. LIFR extracellular region is composed of D1-D2 (Pfam:PF17971) which is a cytokine binding homology region (CHR) followed by an Ig-like domain D3 (Pfam:PF21177), another CHR region composed of D4 and D5 [1-2] and three membrane-proximal fibronectin type-III (FNIII) domains (Pfam:PF00041).
Domain
PF00041Fibronectin type III domain (fn3)Fibronectin type III domainDomain
PF01291LIF / OSM family (LIF_OSM)LIF / OSM familyDomain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

ChainsPolymerMolecular FunctionBiological ProcessCellular Component
Leukemia inhibitory factor receptor
Interleukin-6 receptor subunit beta
Oncostatin-M

Pharos: Disease Associations Pharos Homepage Annotation

ChainsDrug Target  Associated Disease
PharosP42702
PharosP40189
PharosP13725